Meeder Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,015
| Closed | -$2K | – | 2063 |
|
|
2020
Q1 | $2K | Buy |
1,015
+416
| +69% | +$820 | ﹤0.01% | 2059 |
|
|
2019
Q4 | $2K | Buy |
+599
| New | +$2K | ﹤0.01% | 1990 |
|
|
2019
Q3 | – | Sell |
-2,214
| Closed | -$8K | – | 2140 |
|
|
2019
Q2 | $8K | Buy |
+2,214
| New | +$8K | ﹤0.01% | 1513 |
|
|
2019
Q1 | – | Sell |
-786
| Closed | -$6K | – | 1700 |
|
|
2018
Q4 | $6K | Buy |
+786
| New | +$6K | ﹤0.01% | 1361 |
|
|
2017
Q3 | – | Sell |
-156
| Closed | -$1K | – | 1628 |
|
|
2017
Q2 | $1K | Sell |
156
-132
| -46% | -$846 | ﹤0.01% | 1498 |
|
|
2017
Q1 | $2K | Sell |
288
-1,280
| -82% | -$8.89K | ﹤0.01% | 1348 |
|
|
2016
Q4 | $10K | Buy |
+1,568
| New | +$10K | ﹤0.01% | 751 |
|